Stefanovich Robert's Form 4 filing
Cryoport, Inc. (CYRX) · filed Mar 16, 2026
- Accession no.
- 0001104659-26-028775
- Filed
- Mar 16, 2026
- Trade date
- Mar 12-16, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $322.3K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Stefanovich RobertCIK 0001247309 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 12, 2026 | Common Stock | MOption exerciseAcquired | +87,188 | $1.87 | +$163,041.56 | 294,401 | Direct | |
| Mar 12, 2026 | Common Stock | SSaleDisposed | −38,700 | $7.76F2 | −$300,312 | 255,701 | Direct | |
| Mar 14, 2026 | Common Stock | AGrant or awardAcquired | +27,413 | $0.00F3 | $0 | 283,114 | Direct | |
| Mar 16, 2026 | Common Stock | SSaleDisposed | −2,743 | $8.00 | −$21,944 | 280,371 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 12, 2026 | Common Stock | MOption exerciseDisposed | −87,188 | $0.00 | $0 | 0 | Direct | |
| Mar 14, 2026 | Common Stock | AGrant or awardAcquired | +82,240 | $0.00 | $0 | 82,240 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.725 to $7.83, inclusive.
Referenced by the price of 1 transaction in Table I.
- F3
Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning March 14, 2027.
Referenced by the price of 1 transaction in Table I.
Remarks
With respect to prices reported as weighted average prices in Table I, the reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the applicable footnotes to this Form 4.